Novartis Ag (NVS) Property, Plant & Equipment (Net) (2009 - 2026)
Powered by 
Analysis
Novartis Ag (NVS) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 23.58 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 5.80 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 25.74 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 10.69 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 19.03 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 7.79 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 113.37 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 34.61 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 1.64 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | 709.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.69 Bn |
| Mar 31, 2026 | 10.65 Bn |
| Dec 31, 2025 | 10.78 Bn |
| Sep 30, 2025 | 10.48 Bn |
| Jun 30, 2025 | 10.38 Bn |
| Mar 31, 2025 | 9.68 Bn |
| Dec 31, 2024 | 9.46 Bn |
| Sep 30, 2024 | 9.75 Bn |
| Jun 30, 2024 | 9.25 Bn |
| Mar 31, 2024 | 9.20 Bn |
| Dec 31, 2023 | 9.51 Bn |
| Sep 30, 2023 | 9.04 Bn |
| Jun 30, 2023 | 10.83 Bn |
| Mar 31, 2023 | 252.00 Mn |
| Dec 31, 2022 | 10.76 Bn |
| Sep 30, 2022 | 10.32 Bn |
| Jun 30, 2022 | 10.73 Bn |
| Mar 31, 2022 | 13.00 Mn |
| Dec 31, 2021 | 11.55 Bn |
| Sep 30, 2021 | 11.60 Bn |